<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - FMS</title>
<description>International Business News - FMS</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>US regulators approve Fresenius buyout of APP</title>
  <description>APP Pharmaceuticals Inc. said Tuesday U.S. regulators have cleared the way for its purchase by German dialysis-clinic operator Fresenius. In July, Hamburg-based Fresenius announced its plan to purchase APP for $3.7 billion in cash, or $23 per share, plus potential contingent payments of $970 million, or $6 per share. APP said Tuesday it expects the deal to close by mid-September, now that the Federal Trade Commission has completed its review of the transaction. German authorities previously signed off on the deal.</description>
    <link>http://www.ibtimes.com/articles/20080902/us-regulators-approve-fresenius-buyout-of-app.htm</link> 
  <pubDate>Tue, 02 Sep 2008 14:29:17 EDT</pubDate>
  </item>


  <item>
  <title>Fresenius Medical's 2Q profit rises</title>
  <description>Dialysis products maker Fresenius Medical Care AG &amp; Co. KGaA saw its net profit increase by 17 percent in the second quarter, according to preliminary figures released Thursday.</description>
    <link>http://www.ibtimes.com/articles/20080717/fresenius-medicals-2q-profit-rises.htm</link> 
  <pubDate>Thu, 17 Jul 2008 11:47:34 EDT</pubDate>
  </item>


  <item>
  <title>Out of the Gate: APP Pharmaceuticals shares spike</title>
  <description>Shares of APP Pharmaceuticals Inc. skyrocketed Monday after Germany's Fresenius SE said it will buy the U.S. generic drug maker for $3.7 billion in cash.</description>
    <link>http://www.ibtimes.com/articles/20080707/out-of-the-gate-app-pharmaceuticals-shares-spike.htm</link> 
  <pubDate>Mon, 07 Jul 2008 09:46:33 EDT</pubDate>
  </item>


  <item>
  <title>Premarket Movers: Pharma stocks lead mixed session</title>
  <description>Pharmaceutical shares were front and center in premarket trading Monday as U.S. markets appeared headed for a mixed open following the holiday weekend.</description>
    <link>http://www.ibtimes.com/articles/20080707/premarket-movers-pharma-stocks-lead-mixed-session.htm</link> 
  <pubDate>Mon, 07 Jul 2008 08:53:05 EDT</pubDate>
  </item>


  <item>
  <title>Fresenius spent $550K lobbying in first quarter</title>
  <description>Fresenius Medical Care AG, a German dialysis services company, spent $550,000 lobbying the U.S. federal government in the first quarter, according to a recent disclosure report.</description>
    <link>http://www.ibtimes.com/articles/20080627/fresenius-spent-550k-lobbying-in-first-quarter.htm</link> 
  <pubDate>Fri, 27 Jun 2008 16:28:34 EDT</pubDate>
  </item>


  <item>
  <title>Nabi Settles Suit Against Roxane Labs</title>
  <description>
Nabi Biopharmaceuticals said Thursday it has settled its patent-infringement case against Roxane Laboratories Inc. regarding Nabi&amp;#39;s former product PhosLo GelCaps.

The court dismissed the case with ...</description>
    <link>http://www.ibtimes.com/articles/20080403/nabi-settles-suit-against-roxane-labs.htm</link> 
  <pubDate>Thu, 03 Apr 2008 09:51:54 EDT</pubDate>
  </item>


  <item>
  <title>Sector Wrap: Health Care Providers</title>
  <description>
A Wachovia analyst expects chatter surrounding a Medicare bill to escalate over the next two months, potentially causing volatility for certain health care providers' stocks.

Analyst William Bonell...</description>
    <link>http://www.ibtimes.com/articles/20080401/sector-wrap-health-care-providers.htm</link> 
  <pubDate>Tue, 01 Apr 2008 15:37:26 EDT</pubDate>
  </item>


  <item>
  <title>Fresenius Paid Lobbyist $120,000</title>
  <description>Dialysis clinic operator Fresenius Medical Care paid Elmendorf Strategies LLC $120,000 to lobby Congress last year, according to a government disclosure form.</description>
    <link>http://www.ibtimes.com/articles/20080228/fresenius-paid-lobbyist-120-000.htm</link> 
  <pubDate>Thu, 28 Feb 2008 18:47:49 EST</pubDate>
  </item>


</channel>
</rss>